STOCKHOLM–(BUSINESS WIRE)–Apria Healthcare, America’s leading provider of integrated home
healthcare products and services, is taking fulfilment and service
support for the Avance® Max Negative Pressure Wound Therapy system to
acute facilities across the United States.
Mölnlycke Health Care, a world-leading provider of single-use surgical
and wound care products, is announcing today an extended agreement with
Apria Healthcare, allowing patients across the US to benefit from an
advanced wound care technology which limits the spreading of the wound
exudate and can be removed with minimal skin stripping and pain.
Acute care settings across the United States will benefit from the
combination of the Avance® Negative Pressure Wound Therapy (NPWT) with
Safetac® technology and Apria Healthcare’s best-in-class service and
support infrastructure for logistics and billing management.
Safetac technology, combined with the Avance® NPWT provided by Mölnlycke
Health Care, will benefit patients by minimizing skin reactions and pain
during dressing removal, thereby improving overall patient comfort.
Apria Healthcare has a dedicated support team in place – with a 24-hour
hotline supported by professionals at Mölnlycke Health Care.
The Avance® Max Negative Pressure Wound Therapy system (http://www.molnlycke.us/advanced-wound-care-systems/npwt-system/avance-max/), which
is available for acute care settings, is designed to maximize NPWT care
in the hospital, offering a clinically proven, cost-effective solution
for the treatment of wounds. This will complement the Avance® Flex
Negative Pressure Wound Therapy system (http://www.molnlycke.us/advanced-wound-care-systems/npwt-system/avance-flex/)
in home care, where Apria is the exclusive U.S. distributor for
Mölnlycke Health Care, in providing efficient hospital-to-home
transitions and home care NPWT management.
Richard Twomey, CEO of Mölnlycke Health Care, comments: “As the leading
supplier of advanced wound care solutions along the continuum of care,
we are delighted to bring the benefits of Negative Pressure Wound
Therapy to more patients in the US. Our products are clinically proven
to reduce pain at dressing change and our solutions are designed to make
it easier for patients to enjoy their own healing journey.”
Dan Starck, CEO of Apria Healthcare comments: “Together, Apria and
Mölnlycke Health Care are delivering advanced wound care therapy across
the nation in a bigger way than ever before, with an overall better
patient experience. Patient transitions from hospital to home, and the
therapy hand-off are easier and more consistent with the Avance® system
in use from end to end. Transition planning upon admission with product
continuity is now possible, benefitting patients and healthcare
Notes for editors
Mölnlycke Health Care is a provider of high-quality healthcare solutions
for customers, healthcare professionals and patients worldwide. We
develop and bring to market innovative wound care and surgical solutions
along the entire continuum of care – from prevention to post-acute
settings. Our solutions provide good economic value and are supported by
strong clinical evidence.
Mölnlycke Health care employs 7,500 people and is owned by Investor AB (http://www.investorab.com/).
The company headquarters are located in Gothenburg, Sweden, with offices
and factories worldwide.
Apria Healthcare LLC provides home respiratory therapy, home medical
equipment and negative pressure wound therapy through approximately 370
locations across the country. With over $1.1 billion in annual net
revenues, Apria is a leader in the home healthcare industry and one of
the nation’s largest home healthcare companies.
For more information, visit www.apria.com.
This information was brought to you by Cision http://news.cision.com
Mölnlycke Health Care US:
Derek Hughes, Sr. Director, NPWT Sales &
Jeff Johnson, Vice President of Business
949-639-4774 | C 949-614-6014